Short Interest in CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY) Declines By 36.3%

CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY) saw a significant drop in short interest in the month of May. As of May 29th, there was short interest totaling 582 shares, a drop of 36.3% from the May 14th total of 913 shares. Based on an average daily volume of 3,299 shares, the days-to-cover ratio is presently 0.2 days.

CSPC Pharmaceutical Group Price Performance

OTCMKTS:CSPCY opened at C$3.62 on Monday. CSPC Pharmaceutical Group has a 12 month low of C$3.45 and a 12 month high of C$5.83. The company’s 50 day moving average is C$4.18 and its 200-day moving average is C$4.45.

About CSPC Pharmaceutical Group

CSPC Pharmaceutical Group Limited is a China-based pharmaceutical company headquartered in Shijiazhuang, Hebei Province. Established in 1979, the group has grown through organic expansion and strategic acquisitions to become one of the country’s leading manufacturers of active pharmaceutical ingredients (APIs), generic formulations and innovative drug candidates. CSPC is publicly traded in Hong Kong (HKEX: 1093) and maintains American Depositary Receipts on the OTC market (OTCMKTS: CSPCY), reflecting its dual focus on domestic market leadership and international visibility.

The company operates through three primary business segments: bulk pharmaceuticals, finished dosage forms and research-driven products.